nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACOE (The Accreditation Council of Oncology in Europe)
|
|
|
2009 |
45 |
S1 |
p. xxx-xxxi nvt p. |
artikel |
2 |
Advances in fertility preservation for children and adolescents with cancer
|
Donnez, Jacques |
|
2009 |
45 |
S1 |
p. 418- 1 p. |
artikel |
3 |
Allogeneic blood stem cell transplantation
|
Ehninger, Gerhard |
|
2009 |
45 |
S1 |
p. 412-413 2 p. |
artikel |
4 |
Antiemetics: State of the art
|
Herrstedt, Jørn |
|
2009 |
45 |
S1 |
p. 439-441 3 p. |
artikel |
5 |
An update of sentinel node biopsy in breast cancer
|
Mansel, Robert |
|
2009 |
45 |
S1 |
p. 447-448 2 p. |
artikel |
6 |
Beyond the KRAS test
|
Laurent-Puig, Pierre |
|
2009 |
45 |
S1 |
p. 398-399 2 p. |
artikel |
7 |
Biology of cancer and ageing
|
van Heemst, Diana |
|
2009 |
45 |
S1 |
p. 414-415 2 p. |
artikel |
8 |
Bisphosphonates for care and cure
|
Body, Jean-Jacques |
|
2009 |
45 |
S1 |
p. 396-397 2 p. |
artikel |
9 |
Cancer and nutrition: Key determinants of quality of life
|
Ravasco, Paula |
|
2009 |
45 |
S1 |
p. 409- 1 p. |
artikel |
10 |
Cancer stem cells and the cellular hierarchy in haematological malignancies
|
Johnsen, Hans Erik |
|
2009 |
45 |
S1 |
p. 194-201 8 p. |
artikel |
11 |
Cardiac disease and second lung cancer after radiotherapy for breast cancer
|
Correa, Candace R. |
|
2009 |
45 |
S1 |
p. 420-421 2 p. |
artikel |
12 |
Cardiovascular toxicity of molecularly targeted agents
|
Strevel, Elizabeth L. |
|
2009 |
45 |
S1 |
p. 318-331 14 p. |
artikel |
13 |
Cervical cancer and vaccination — an overview
|
Joura, Elmar A. |
|
2009 |
45 |
S1 |
p. 457-458 2 p. |
artikel |
14 |
Chairperson's Introduction
|
Senn, Hans-Joerg |
|
2009 |
45 |
S1 |
p. 344-345 2 p. |
artikel |
15 |
Chairperson's Introduction
|
Ellis, Ian |
|
2009 |
45 |
S1 |
p. 4- 1 p. |
artikel |
16 |
Chairpersons' Introduction
|
Wiegel, Thomas |
|
2009 |
45 |
S1 |
p. 138-139 2 p. |
artikel |
17 |
Chairperson's Introduction
|
Öberg, Kjell |
|
2009 |
45 |
S1 |
p. 236- 1 p. |
artikel |
18 |
Chairperson's Introduction
|
Twelves, C. |
|
2009 |
45 |
S1 |
p. 294- 1 p. |
artikel |
19 |
Chairperson's Introduction
|
Sobrero, Alberto |
|
2009 |
45 |
S1 |
p. 42- 1 p. |
artikel |
20 |
Chairperson's Introduction
|
Vansteenkiste, Johan |
|
2009 |
45 |
S1 |
p. 90-91 2 p. |
artikel |
21 |
Chairperson's Introduction
|
Alison, Malcolm R. |
|
2009 |
45 |
S1 |
p. 174- 1 p. |
artikel |
22 |
Chairperson's Introduction
|
Gullick, William J. |
|
2009 |
45 |
S1 |
p. 204- 1 p. |
artikel |
23 |
Chemotherapy in patients with castration-resistant prostate cancer
|
Meulenbeld, Hielke J. |
|
2009 |
45 |
S1 |
p. 161-171 11 p. |
artikel |
24 |
Chemotherapy in stage III non-small cell lung cancer
|
Eberhardt, Wilfried E.E. |
|
2009 |
45 |
S1 |
p. 126-136 11 p. |
artikel |
25 |
Chemotherapy, which drugs and when
|
Koopman, Miriam |
|
2009 |
45 |
S1 |
p. 50-56 7 p. |
artikel |
26 |
Clinical predictive factors
|
Köhne, Claus-Henning |
|
2009 |
45 |
S1 |
p. 43-49 7 p. |
artikel |
27 |
Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept
|
Linn, Sabine C. |
|
2009 |
45 |
S1 |
p. 11-26 16 p. |
artikel |
28 |
Colorectal cancer chemoprevention: Ready for practice?
|
Kraus, Sarah |
|
2009 |
45 |
S1 |
p. 360-366 7 p. |
artikel |
29 |
Current challenges in lung cancer early detection biomarkers
|
Montuenga, Luis M. |
|
2009 |
45 |
S1 |
p. 377-378 2 p. |
artikel |
30 |
Current standards and options in the treatment of squamous cell oesophageal carcinoma
|
Mariette, Christophe |
|
2009 |
45 |
S1 |
p. 452-454 3 p. |
artikel |
31 |
Current treatment of high risk testis cancer
|
Schmoll, H.-J. |
|
2009 |
45 |
S1 |
p. 433-435 3 p. |
artikel |
32 |
Desmoid-type fibromatosis: What works best?
|
Colombo, Chiara |
|
2009 |
45 |
S1 |
p. 466-467 2 p. |
artikel |
33 |
Developments in early rectal cancer treatment
|
Bach, Simon P. |
|
2009 |
45 |
S1 |
p. 464-465 2 p. |
artikel |
34 |
ECCO 15 — ESMO 34 Congress Committees
|
|
|
2009 |
45 |
S1 |
p. viii-ix nvt p. |
artikel |
35 |
ECCO — the European CanCer Organisation
|
|
|
2009 |
45 |
S1 |
p. x- 1 p. |
artikel |
36 |
ECCO – the European CanCer Organisation Advisory Members
|
|
|
2009 |
45 |
S1 |
p. xxii-xxix nvt p. |
artikel |
37 |
ECCO – the European CanCer Organisation Founding Members
|
|
|
2009 |
45 |
S1 |
p. xiii-xvi nvt p. |
artikel |
38 |
ECCO – the European CanCer Organisation Full Members
|
|
|
2009 |
45 |
S1 |
p. xvii-xxi nvt p. |
artikel |
39 |
Editorial Board
|
|
|
2009 |
45 |
S1 |
p. ii- 1 p. |
artikel |
40 |
Epigenetic information in chromatin and cancer
|
Herceg, Zdenko |
|
2009 |
45 |
S1 |
p. 442-444 3 p. |
artikel |
41 |
European Society for Medical Oncology (ESMO)
|
|
|
2009 |
45 |
S1 |
p. xi-xii nvt p. |
artikel |
42 |
Evidence-based medicine: Development and implementation of guidelines in oncology
|
Pavlidis, Nicholas |
|
2009 |
45 |
S1 |
p. 468-470 3 p. |
artikel |
43 |
Functional image-guided intensity modulated radiation therapy: Integration of the tumour microenvironment in treatment planning
|
Grégoire, V. |
|
2009 |
45 |
S1 |
p. 459-460 2 p. |
artikel |
44 |
Gastrointestinal toxicities of novel agents in cancer therapy
|
Asnacios, Amani |
|
2009 |
45 |
S1 |
p. 332-342 11 p. |
artikel |
45 |
Genomic profiling of colorectal cancer
|
Coyle, Vicky M. |
|
2009 |
45 |
S1 |
p. 371-374 4 p. |
artikel |
46 |
Hormonal treatment for progression
|
Miller, Kurt |
|
2009 |
45 |
S1 |
p. 158-160 3 p. |
artikel |
47 |
How to integrate biologicals in the continuum of care
|
Venugopal, B. |
|
2009 |
45 |
S1 |
p. 57-69 13 p. |
artikel |
48 |
How to use functional imaging information for radiotherapy planning
|
Grosu, Anca-Ligia |
|
2009 |
45 |
S1 |
p. 461-463 3 p. |
artikel |
49 |
HPV and prognosis for patients with oropharynx cancer
|
Gillison, Maura L. |
|
2009 |
45 |
S1 |
p. 383-385 3 p. |
artikel |
50 |
Impact of molecular markers on treatment selection in advanced colorectal cancer
|
Prenen, Hans |
|
2009 |
45 |
S1 |
p. 70-78 9 p. |
artikel |
51 |
IMRT and molecular biological approaches in radiotherapy for prostate cancer
|
Bristow, Robert G. |
|
2009 |
45 |
S1 |
p. 429-430 2 p. |
artikel |
52 |
Introduction
|
Schrijvers, Dirk |
|
2009 |
45 |
S1 |
p. xxxiii- 1 p. |
artikel |
53 |
Lung cancer screening with low dose computed tomography: Where do we stand today?
|
van Klaveren, R.J. |
|
2009 |
45 |
S1 |
p. 375-376 2 p. |
artikel |
54 |
Lung tumours with neuroendocrine differentiation
|
Travis, William D. |
|
2009 |
45 |
S1 |
p. 251-266 16 p. |
artikel |
55 |
Mammary epithelial and breast cancer stem cells
|
Groner, Bernd |
|
2009 |
45 |
S1 |
p. 186-193 8 p. |
artikel |
56 |
Management and interpretation of novel toxicities of molecular targeted therapies: Renal toxicities
|
Carles, Joan |
|
2009 |
45 |
S1 |
p. 309-317 9 p. |
artikel |
57 |
MicroRNAs and their antagonists as novel therapeutics
|
Shomron, Noam |
|
2009 |
45 |
S1 |
p. 388-390 3 p. |
artikel |
58 |
Minichromosome maintenance proteins in cancer screening
|
Coleman, Nicholas |
|
2009 |
45 |
S1 |
p. 416-417 2 p. |
artikel |
59 |
Multiple endocrine neoplasia type 2 (MEN 2)
|
Frank-Raue, Karin |
|
2009 |
45 |
S1 |
p. 267-273 7 p. |
artikel |
60 |
Neoadjuvant chemotherapy for breast cancers: Current recommendations and future directions
|
Andre, Fabrice |
|
2009 |
45 |
S1 |
p. 368-370 3 p. |
artikel |
61 |
New agents in metastatic prostate cancer
|
Fizazi, Karim |
|
2009 |
45 |
S1 |
p. 379-380 2 p. |
artikel |
62 |
New approaches and targets in advanced colorectal cancer
|
Macarulla, Teresa |
|
2009 |
45 |
S1 |
p. 79-88 10 p. |
artikel |
63 |
Particle therapy — Physical, technical and clinical aspects
|
Debus, Jürgen |
|
2009 |
45 |
S1 |
p. 381-382 2 p. |
artikel |
64 |
Pathological definition of triple negative breast cancer
|
Viale, Giuseppe |
|
2009 |
45 |
S1 |
p. 5-10 6 p. |
artikel |
65 |
p53: Balancing tumour suppression and implications for the clinic
|
Buganim, Yosef |
|
2009 |
45 |
S1 |
p. 217-234 18 p. |
artikel |
66 |
Pharmacokinetics and pharmacodynamic biomarkers in early oncology drug development
|
Takimoto, Chris H. |
|
2009 |
45 |
S1 |
p. 436-438 3 p. |
artikel |
67 |
Portrait of invasive lobular carcinoma of the breast
|
Pestalozzi, Bernhard C. |
|
2009 |
45 |
S1 |
p. 450-451 2 p. |
artikel |
68 |
Prostate cancer — chemoprevention
|
Schröder, Fritz H. |
|
2009 |
45 |
S1 |
p. 355-359 5 p. |
artikel |
69 |
PSA screening — a review of recent studies
|
Schröder, Fritz H. |
|
2009 |
45 |
S1 |
p. 402-404 3 p. |
artikel |
70 |
Psycho-science: Where do we go from here?
|
Walker, Leslie G. |
|
2009 |
45 |
S1 |
p. 455-456 2 p. |
artikel |
71 |
Radiotherapy for locally advanced non-small cell lung cancer
|
Girard, Nicolas |
|
2009 |
45 |
S1 |
p. 113-125 13 p. |
artikel |
72 |
Rare tumours of the chest
|
Muñoz, E. |
|
2009 |
45 |
S1 |
p. 400-401 2 p. |
artikel |
73 |
RAS in cellular transformation and senescence
|
DeNicola, Gina M. |
|
2009 |
45 |
S1 |
p. 211-216 6 p. |
artikel |
74 |
Re-irradiation of brain tumours — evidence, indications and limitations
|
Short, S.C. |
|
2009 |
45 |
S1 |
p. 410-411 2 p. |
artikel |
75 |
Role of radiopharmaceuticals in the diagnosis and treatment of neuroendocrine tumours
|
Virgolini, Irene J. |
|
2009 |
45 |
S1 |
p. 274-291 18 p. |
artikel |
76 |
Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer
|
Bottke, Dirk |
|
2009 |
45 |
S1 |
p. 148-157 10 p. |
artikel |
77 |
Screening for colorectal cancer, where are we now?
|
Kraus, Sarah |
|
2009 |
45 |
S1 |
p. 422-424 3 p. |
artikel |
78 |
Skin toxicities of targeted therapies
|
Segaert, Siegfried |
|
2009 |
45 |
S1 |
p. 295-308 14 p. |
artikel |
79 |
Stem cells and cancer in the aerodigestive tract
|
Alison, Malcolm R. |
|
2009 |
45 |
S1 |
p. 175-185 11 p. |
artikel |
80 |
Subclassification of ovarian cancer based on pathology and genetics
|
Prat, Jaime |
|
2009 |
45 |
S1 |
p. 427-428 2 p. |
artikel |
81 |
Surgical aspects of neuroendocrine tumours
|
Åkerström, Göran |
|
2009 |
45 |
S1 |
p. 237-250 14 p. |
artikel |
82 |
Surgical treatment of stage III non-small cell lung cancer
|
Van Schil, Paul E. |
|
2009 |
45 |
S1 |
p. 106-112 7 p. |
artikel |
83 |
The challenge of interacting with patients in oncology
|
Fallowfield, Lesley |
|
2009 |
45 |
S1 |
p. 445-446 2 p. |
artikel |
84 |
The epidermal growth factor system of ligands and receptors in cancer
|
Gullick, William J. |
|
2009 |
45 |
S1 |
p. 205-210 6 p. |
artikel |
85 |
The multidisciplinarity of stage III non-small cell lung cancer
|
Vansteenkiste, Johan |
|
2009 |
45 |
S1 |
p. 92-105 14 p. |
artikel |
86 |
Therapy of diffuse large B-cell lymphomas
|
Pfreundschuh, M. |
|
2009 |
45 |
S1 |
p. 386-387 2 p. |
artikel |
87 |
The rationale and potential of cancer chemoprevention with special emphasis on breast cancer
|
Puntoni, Matteo |
|
2009 |
45 |
S1 |
p. 346-354 9 p. |
artikel |
88 |
The value of new imaging technology for target volume delineation
|
Khoo, V. |
|
2009 |
45 |
S1 |
p. 405-408 4 p. |
artikel |
89 |
Treatment of limited disease small cell lung cancer
|
De Ruysscher, Dirk |
|
2009 |
45 |
S1 |
p. 425-426 2 p. |
artikel |
90 |
Treatment of local progression following radiotherapy
|
de Reijke, Theo M. |
|
2009 |
45 |
S1 |
p. 140-147 8 p. |
artikel |
91 |
Triple negative breast cancers: Clinical and prognostic implications
|
Dawson, S.J. |
|
2009 |
45 |
S1 |
p. 27-40 14 p. |
artikel |
92 |
Value of quality indicators for cancer services
|
Wagner, Ulrich |
|
2009 |
45 |
S1 |
p. 431-432 2 p. |
artikel |
93 |
Whole body optical imaging in small animals and its translation to the clinic: Intra-operative optical imaging guided surgery
|
Löwik, C.W.G.M. |
|
2009 |
45 |
S1 |
p. 391-393 3 p. |
artikel |